Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr-Jun;29(2):195-200.
doi: 10.4103/ijri.IJRI_383_18.

Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads

Ahmed E Hassan  1 , Radwa E Mostafa  1 , Ayman Nada  2 , Mohamed S Elazab  1 , Ahmed Sayed Awad  3 , Ikram M Hamed  1
Affiliations

Diagnostic accuracy of intermediate b-value diffusion-weighted imaging for detection of residual hepatocellular carcinoma following transarterial chemoembolization with drug-eluting beads

Ahmed E Hassan et al. Indian J Radiol Imaging. 2019 Apr-Jun.

Abstract

Purpose: To evaluate the role of diffusion-weighted magnetic resonance imaging (DW-MRI) in the detection of residual malignant tumor of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) with drug-eluting beads (DEBs).

Subjects and methods: Pre-contrast T1, T2, dynamic contrast-enhanced, and respiratory-triggered DW-MRI (b factor 0, 400, and 800 s/mm2) were obtained in 60 patients with HCC who underwent tran-sarterial hepatic chemoembolization with DEBs. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the DW imaging images. Apparent diffusion coefficients (ADCs) were calculated searching for the optimal cut-off value using the receiver operating characteristic (ROC) curve.

Results: DW-MRI had a sensitivity of 77.1%, a specificity of 60.7%, a PPV of 71.05%, and a NPV of 68%. The difference between the malignant and benign groups' ADC variables was statistically significant (P < 0.003). The ROC curve showed that the area under the curve is C = 0.718 with SE = 0.069 and 95% confidence interval from 0.548 to 0.852.

Conclusion: In our study, we demonstrated that diffusion MRI has limited diagnostic value in the assessment of viable tumor tissue after TACE with DEBs in cases of HCC.

Keywords: Drug-eluting beads; diffusion-weighted magnetic resonance imaging; hepatic; hepatocellular carcinoma-transcatheter arterial chemoembolization; malignant.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
A 71-year-old male treated with DEB-TACE for HCC. DWIs of the lesion showed peripheral bright areas that became brighter with increasing the b value (0, 400, 800) in successive images from the top two rows with dark signal in the ADC map denoting restricted diffusion “arrows.” Dynamic thrive images showed necrosis of the lesion with thin smooth rim of reactive enhancement “arrows.” The bright T1 signal in the precontrast image represents coagulative necrosis
Figure 2
Figure 2
A 65-year-old female treated with DEB-TACE for HCC. DWIs showed central bright areas that became brighter with increasing the b value (0, 400, 800) in successive images from the top images with dark signal in the ADC map denoting restricted diffusion. Dynamic thrive images showed marginal reactive enhancement with no evidence of early pathological enhancement or washout of contrast “arrows” denoting good therapeutic response with no residual tumoral activity. The bright T1 signal in the precontrast image represents coagulative necrosis
Figure 3
Figure 3
A 68-year-old male treated with DEB-TACE for HCC. DWIs of the lesion showed peripheral bright areas that became brighter with increasing the b value (0, 400, 800) in successive images from the top images with dark signal in the ADC map denoting restricted diffusion. Dynamic thrive images also showed heterogeneous enhancement with nodular vivid enhancement in the arterial and portal phases with delayed contrast washout matching the nodules of restricted diffusion pattern “arrows” denoting residual viable tumoral activity. The precontrast images show hyperintense T1 signal, suggestive of hemorrhagic foci
Figure 4
Figure 4
Results of receiver operating curves for ADC values in distinguishing benign and malignant groups
See this image and copyright information in PMC

References

    1. Lee S, Park KA, Choi SY. MRI findings and prediction of time to progression of patients with hepatocellular carcinoma treated with drug-eluting bead transcatheter arterial chemoembolization. J Korean Med Sci. 2015;30:965–73. - PMC - PubMed
    1. Corona-Villalobos CP, Halappa VG, Geschwind JF, Bonekamp S, Reyes D, Cosgrove D, et al. Volumetric assessment of tumor response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib. Eur Radiol. 2015;25:380–90. - PMC - PubMed
    1. Özkavukcu E, Haliloǧlu N, Erden A. Post-treatment MRI findings of hepatocellular carcinoma. Diagn Interv Radiol. 2009;15:111–20. - PubMed
    1. Kamel IR, Morgan HR. MRI appearance of treated liver lesions. Proc Intl Soc Mag Reson Med. 2011;19
    1. Kele PG, van der Jagt EJ. Diffusion weighted imaging in the liver. World J Gastroenterol. 2010;16:1567–76. - PMC - PubMed